• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侧窗为A1899与TASK-1钾通道孔的稳定结合提供了一个“锚点”。

Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels.

作者信息

Ramírez David, Arévalo Bárbara, Martínez Gonzalo, Rinné Susanne, Sepúlveda Francisco V, Decher Niels, González Wendy

机构信息

Centro de Bioinformática y Simulación Molecular, Universidad de Talca , 1 poniente No. 1141, 3460000 Talca, Chile.

Instituto de Ciencias Biomédicas, Universidad Autonoma de Chile , 5 Poniente No. 1670, 3460000 Talca, Chile.

出版信息

Mol Pharm. 2017 Jul 3;14(7):2197-2208. doi: 10.1021/acs.molpharmaceut.7b00005. Epub 2017 May 30.

DOI:10.1021/acs.molpharmaceut.7b00005
PMID:28494157
Abstract

A1899 is a potent and selective inhibitor of the two-pore domain potassium (K) channel TASK-1. It was previously reported that A1899 acts as an open-channel blocker and binds to residues of the P1 and P2 regions, the M2 and M4 segments, and the halothane response element. The recently described crystal structures of K channels together with the newly identified side fenestrations indicate that residues relevant for TASK-1 inhibition are not purely facing the central cavity as initially proposed. Accordingly, the TASK-1 binding site and the mechanism of inhibition might need a re-evaluation. We have used TASK-1 homology models based on recently crystallized K channels and molecular dynamics simulation to demonstrate that the highly potent TASK-1 blocker A1899 requires binding to residues located in the side fenestrations. Unexpectedly, most of the previously described residues that interfere with TASK-1 blockade by A1899 project their side chains toward the fenestration lumina, underlining the relevance of these structures for drug binding in K channels. Despite its hydrophobicity, A1899 does not seem to use the fenestrations to gain access to the central cavity from the lipid bilayer. In contrast, binding of A1899 to residues of the side fenestrations might provide a physical "anchor", reflecting an energetically favorable binding mode that after pore occlusion stabilizes the closed state of the channels.

摘要

A1899是双孔域钾(K)通道TASK-1的一种强效且选择性的抑制剂。此前有报道称,A1899作为一种开放通道阻滞剂,与P1和P2区域、M2和M4片段以及氟烷反应元件的残基结合。最近描述的钾通道晶体结构以及新发现的侧窗表明,与TASK-1抑制相关的残基并非如最初所提出的那样纯粹面向中央腔。因此,TASK-1结合位点和抑制机制可能需要重新评估。我们使用基于最近结晶的钾通道的TASK-1同源模型和分子动力学模拟来证明,强效的TASK-1阻滞剂A1899需要与位于侧窗中的残基结合。出乎意料的是,大多数先前描述的干扰A1899对TASK-1阻断作用的残基将其侧链伸向窗腔,突出了这些结构在钾通道药物结合中的相关性。尽管A1899具有疏水性,但它似乎并未利用侧窗从脂质双层进入中央腔。相反,A1899与侧窗残基的结合可能提供一个物理“锚定”,反映出一种能量上有利的结合模式,在孔道堵塞后稳定通道的关闭状态。

相似文献

1
Side Fenestrations Provide an "Anchor" for a Stable Binding of A1899 to the Pore of TASK-1 Potassium Channels.侧窗为A1899与TASK-1钾通道孔的稳定结合提供了一个“锚点”。
Mol Pharm. 2017 Jul 3;14(7):2197-2208. doi: 10.1021/acs.molpharmaceut.7b00005. Epub 2017 May 30.
2
A specific two-pore domain potassium channel blocker defines the structure of the TASK-1 open pore.一种特定的双孔域钾通道阻断剂定义了 TASK-1 开放孔的结构。
J Biol Chem. 2011 Apr 22;286(16):13977-84. doi: 10.1074/jbc.M111.227884. Epub 2011 Mar 1.
3
Identification of the A293 (AVE1231) Binding Site in the Cardiac Two-Pore-Domain Potassium Channel TASK-1: a Common Low Affinity Antiarrhythmic Drug Binding Site.心脏双孔结构域钾通道TASK-1中A293(AVE1231)结合位点的鉴定:一个常见的低亲和力抗心律失常药物结合位点。
Cell Physiol Biochem. 2019;52(5):1223-1235. doi: 10.33594/000000083.
4
Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.呼吸刺激化合物可能通过结合于通道孔的一个共同位点来抑制TASK-3钾通道功能。
Mol Pharmacol. 2015 Nov;88(5):926-34. doi: 10.1124/mol.115.100107. Epub 2015 Aug 12.
5
TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats.TASK-1(KCNK3)和 TASK-3(KCNK9)串联孔钾通道拮抗剂可刺激异氟烷麻醉大鼠的呼吸。
Anesth Analg. 2013 Apr;116(4):810-6. doi: 10.1213/ANE.0b013e318284469d. Epub 2013 Mar 4.
6
Elucidating the Structural Basis of the Intracellular pH Sensing Mechanism of TASK-2 KP Channels.阐明 TASK-2 钾通道细胞内 pH 感应机制的结构基础。
Int J Mol Sci. 2020 Jan 14;21(2):532. doi: 10.3390/ijms21020532.
7
A1899, PK-THPP, ML365, and Doxapram inhibit endogenous TASK channels and excite calcium signaling in carotid body type-1 cells.A1899、PK-THPP、ML365和多沙普仑抑制内源性TASK通道并激发颈动脉体1型细胞中的钙信号传导。
Physiol Rep. 2018 Sep;6(19):e13876. doi: 10.14814/phy2.13876.
8
The molecular basis for an allosteric inhibition of K-flux gating in K channels.K 通道中变构抑制 K 流门控的分子基础。
Elife. 2019 Feb 26;8:e39476. doi: 10.7554/eLife.39476.
9
Low pH boosts burst firing and catecholamine release by blocking TASK-1 and BK channels while preserving Cav1 channels in mouse chromaffin cells.低pH值通过阻断小鼠嗜铬细胞中的TASK-1和BK通道,同时保留Cav1通道,增强爆发式放电和儿茶酚胺释放。
J Physiol. 2017 Apr 15;595(8):2587-2609. doi: 10.1113/JP273735. Epub 2017 Mar 2.
10
Influence of lipids on the hydrophobic barrier within the pore of the TWIK-1 K2P channel.脂质对TWIK-1 K2P通道孔内疏水屏障的影响。
Channels (Austin). 2015;9(1):44-9. doi: 10.4161/19336950.2014.981987.

引用本文的文献

1
Potassium channel TASK-5 forms functional heterodimers with TASK-1 and TASK-3 to break its silence.钾通道 TASK-5 与 TASK-1 和 TASK-3 形成功能性异二聚体以打破其沉默。
Nat Commun. 2024 Aug 30;15(1):7548. doi: 10.1038/s41467-024-51288-8.
2
Advances in the Understanding of Two-Pore Domain TASK Potassium Channels and Their Potential as Therapeutic Targets.双孔域 TASK 钾通道的理解进展及其作为治疗靶点的潜力。
Molecules. 2022 Nov 28;27(23):8296. doi: 10.3390/molecules27238296.
3
Energetic differences between non-domain-swapped and domain-swapped chain connectivities in the K2P potassium channel TRAAK.
K2P钾通道TRAAK中非结构域交换和结构域交换链连接之间的能量差异。
RSC Adv. 2018 Jul 25;8(47):26610-26618. doi: 10.1039/c8ra04159h. eCollection 2018 Jul 24.
4
Structural Insights into the Substrate Transport Mechanisms in GTR Transporters through Ensemble Docking.通过集合 docking 研究 GTR 转运蛋白中底物转运机制的结构见解。
Int J Mol Sci. 2022 Jan 29;23(3):1595. doi: 10.3390/ijms23031595.
5
5-(Indol-2-yl)pyrazolo[3,4-]pyridines as a New Family of TASK-3 Channel Blockers: A Pharmacophore-Based Regioselective Synthesis.5-(吲哚-2-基)吡唑并[3,4-b]吡啶类作为 TASK-3 通道阻断剂的新家族:基于药效团的区域选择性合成。
Molecules. 2021 Jun 25;26(13):3897. doi: 10.3390/molecules26133897.
6
Screening for Interacting Proteins with Peptide Biomarker of Blood-Brain Barrier Alteration under Inflammatory Conditions.筛选与炎症条件下血脑屏障改变的肽生物标志物相互作用的蛋白质。
Int J Mol Sci. 2021 Apr 29;22(9):4725. doi: 10.3390/ijms22094725.
7
Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels.雷诺嗪的抗心律失常特性:对心房颤动相关TASK-1钾通道的抑制作用。
Front Pharmacol. 2019 Nov 26;10:1367. doi: 10.3389/fphar.2019.01367. eCollection 2019.
8
Elucidating the Structural Basis of the Intracellular pH Sensing Mechanism of TASK-2 KP Channels.阐明 TASK-2 钾通道细胞内 pH 感应机制的结构基础。
Int J Mol Sci. 2020 Jan 14;21(2):532. doi: 10.3390/ijms21020532.
9
Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening.基于药效团的虚拟筛选发现新型 TASK-3 通道阻断剂。
Int J Mol Sci. 2019 Aug 17;20(16):4014. doi: 10.3390/ijms20164014.
10
Structure/Activity Analysis of TASK-3 Channel Antagonists Based on a 5,6,7,8 tetrahydropyrido[4,3-d]pyrimidine.基于 5,6,7,8-四氢吡啶并[4,3-d]嘧啶的 TASK-3 通道拮抗剂的结构/活性分析。
Int J Mol Sci. 2019 May 7;20(9):2252. doi: 10.3390/ijms20092252.